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1. Introduction    
Embryonic stem (ES) cells are derivatives of the inner cell mass from pre-implantation 
blastocysts of early mammalian embryos. They are uncommitted and pluripotent cells with 
a characteristic high self renewal potential. If propagated under appropriate tissue culture 
conditions they can proliferate indefinitely while maintaining a high genomic stability and 
are in fact immortal. An important contributor to these properties is a high amount of 
telomerase activity. This occurs mainly via the telomere maintenance function of telomerase. 
However, recently it has also been shown that telomerase can localise to mitochondria and 
decrease intracellular oxidative stress.  
The final goal for the use of human embryonic stem cells (ESC) is to generate differentiated 
cells and products for cell replacement therapies. For this purpose, embryonic stem cells can 
be induced to differentiate into cells from all three germ layers: mesoderm, entoderm and 
ectoderm and eventually give rise to all somatic cell type of the human body. In vitro, this 
requires specialised growth conditions and factors which are often defined empirically 
rather than due to scientific evidence. For example, it emerges recently that growing ES cells 
under low, physiological oxygen conditions rather than atmospheric oxygen (21%) are 
greatly beneficial for the properties and application of these cells. 
This chapter will summarise our current knowledge on telomerase expression and oxygen 
conditions and their involvement in the maintenance of self-renewal, pluripotency and stem 
cell differentiation. 
2. Telomerase expression in ES cells 
There exist several factors which are known to contribute to ESCs pluripotency. Among 
them there are the transcription factors Oct4, Sox2, NANOG as well as a constitutively high 
level of telomerase expression. All these factors are down regulated during differentiation of 
ESCs into various cells and tissues. The only exception to that are germ line cells which 
continue to express high amounts of telomerase. The mechanisms of maintaining 
pluripotency differ in mouse and human ES cells. While the murine system requires both 
LIF and BMP4 for self-renewal human ESC culture needs to be supplemented with basic 
fibroblast factors and the TGFβ/Activin/Nodal pathway has to be activated.  
The ribonucleoprotein telomerase is a unique reverse transcriptase that consists of two main 
parts: TERT, the catalytic subunit and TR or TERC, the RNA component that contains the 
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template region for the synthesis of telomeric repeats. The main and best studied function of 
telomerase is the extention of telomeres. Telomeres are the end of chromosomes and protect 
them from genomic instabilities. Telomeres in cells without or with rather low levels of 
telomerase shorten continuously (Harley et al., 1990) due to loss of sequences caused by 
inability of conventional polymerases to fill the gap of the last RNA primer at the lagging 
strand synthesis as well as to oxidative stress (von Zglinicki et al., 1995). There is an 
important difference between mouse and humans regarding the expression of telomerase in 
somatic cells and tissues. While telomerase expression persists in many adult tissues in mice 
in humans telomerase levels are high during early embryonic development, but then down 
regulated during development. Therefore, only some cell and tissue types in the adult 
human body retain telomerase activity such as endothelial cells and lymphocytes while 
adult stem cells are able to activate telomerase upon activation. However, a stable 
maintenance of telomeres is necessary for ongoing cellular proliferation and immortality. 
Embryonic stem cells share a high level of telomerase expression with cancer cells but they 
are characterised by a high genomic stability. The physiological regulation and fine-tuning 
of telomerase expression occurs at multiple levels including transcriptional, post-
transcriptional, post-translational and different sub-cellular localisations.  
In addition to telomere maintenance that is of particular significance in vigorously 
proliferating cells, non-telomeric functions of telomerase have been described recently (for 
review see Saretzki, 2009). These include interference of the catalytic subunit TERT with 
important signalling pathways of stem cells and early embryonic development such as 
WNT and myc (Choi et al., 2008). These pathways are also important for embryonic stem 
cells. Recently it has been demonstrated that TERT can function as a transcriptional co-factor 
that modulates chromatin structure and activates genes downstream of the WNT signalling 
pathway (Park et al., 2009). No RNA component or catalytic function are necessary for this 
non-canonical function of telomerase. Although these studies have been performed in adult 
stem cells one can speculate that telomerase/TERT might have additional, non-telomere 
roles in embryonic stem cells as well. However, so far no studies have been performed to 
address this issue. 
It is also known that the presence of telomerase correlates to cellular survival under 
conditions of DNA damage and stress. While over- expression of telomerase protects 
various cell types including embryonic stem cells (Fu et al., 2000, Zhu et al., 2000, Zhang et 
al., 2003, Armstrong et al., 2005, Ahmed et al., 2008, Yang et al., 2008) telomerase inhibition 
can lead to increased apoptosis and increased sensitivity against cellular stress including 
treatment with chemotherapeutic drugs (Kondo et al., 1998, Saretzki et al., 2001, Ludwig et 
al., 2001, Yang et al.2008).  
In addition, it has been demonstrated that telomerase can be excluded from the nucleus 
under oxidative stress and localise to the mitochondria (Santos et al., 2004, Ahmed et al., 
2008, Haendeler et al., 2009). This can improve mitochondrial function, decrease cellular 
oxidative stress and protect cells from apoptosis and DNA damage (Ahmed et al., 2008, 
Haendeler et al., 2009). However, no detailed studies on the relationship between telomerase 
expression and mitochondrial properties, including generation of reactive oxygen species 
(ROS) have been performed on embryonic stem cells although we have preliminary data 
that show a mitochondrial localisation of TERT protein within mitochondria in human 
embryonic stem cells (unpublished data). It is likely that other factors than oxidative stress 
can promote mitochondrial localisation of telomerase in order to provide a pro-survival 
function. Since telomerase is able to shuttle from the nucleus to the mitochondria it can carry 
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out nuclear functions such as telomere maintenance or interference with gene expression 
and transcription in parallel with any potential function at other cellular locations including 
mitochondria. However, this fact also makes it difficult to separate the various functions of 
telomerase within a cell. Over-expression of telomerase in mouse and human embryonic 
stem cells improved many stem cell parameters including proliferation and colony forming 
abilities (Armstrong et al., 2005, Yang et al., 2008). However, the differentiated progeny from 
TERT over-expressing stem cells maintained high telomerase levels and showed less 
intracellular oxidative stress as well as higher apoptosis resistance (Armstrong et al., 2005, 
Lee et al., 2005, Yang et al., 2008).   
In contrast, down regulation of TERT expression in ES cells correlated either with immediate 
spontaneous differentiation or decreased proliferation rates demonstrating the importance of a 
high telomerase for pluripotency in human embryonic stem cells (Yang et al., 2008). 
3. Telomerase activity and differentiation 
A constant high telomerase expression is a hallmark of pluripotent human stem cells (Amit 
et al., 2000). In contrast, it is lower, although strongly inducible in adult human stem cells 
(Hiyama and Hiyama, 2007). Down regulation of telomerase expression strongly correlates 
with the in vitro differentiation process in both embryonic and adult stem cells resembling 
the situation in vivo very closely (Saretzki et al., 2008, O’Connor et al., 2009).  
We have shown previously that down regulation of telomerase as well as other pluripotency 
factors such as Sox2, Oct4 and NANOG and increase of oxidative stress, DNA damage and 
mitochondrial biogenesis in embryonic stem cells coincided in time when cells were 
differentiating (Armstrong et al., 2000, Saretzki et al., 2008). However, it is not known 
whether there is a causal interplay between these factors during the differentiation process. 
The differentiated progeny of ESCs down regulated telomerase within a week, shorten 
telomeres and accumulate DNA damage (Saretzki et al., 2008). The mechanism for this 
down regulation seem to be epigenetic processes such as methylation and acetylation of the 
TERT and, perhaps to a lesser extend, the TERC promoters (Lopatina et al., 2003, Atkinson 
et al., 2005, Saretzki et al., 2008). However, additional mechanisms for down regulation of 
telomerase such as polyunsaturated fatty acids have been described as well (Eitsuka et  
al., 2005).  
In general, it seems important that endogenous telomerase is down regulated during 
differentiation of ESCs as well as cancer cells (Bagheri et al., 2006, Li et al., 2005). However, it 
is not entirely clear whether down regulation of telomerase activity is merely associated or 
even necessary for differentiation of ESC. 
Therefore studies which analyse over-expression or inhibition of telomerase in ESCs are 
very informative to address this question. Over-expression was achieved by constitutively 
over-expressing TERT, the catalytic subunit of telomerase in ES cells. Over-expression of 
TERT further potentiated the pluripotency and proliferation capacities of mouse and human 
ESCs (Armstrong et al., 2005, Yang et al., 2008). TERT over-expression resulted in a higher 
proliferation rate due to an increased fraction of cells in S-phase in mouse as well as human 
ES cells (Armstrong et al., 2005, Yang et al., 2008). However, differentiation capabilities after 
TERT over-expression varied between mouse and human ESCs and between different 
studies (Armstrong et al., 2005, Lee et al., 2005, Yang et al., 2008). While endogenous 
telomerase is normally down regulated during differentiation of ES cells ectopic telomerase 
remained stably expressed  in the differentiated progeny (Armstrong et al., 2005, Yang et al., 
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2008). TERT over-expressing mouse ESCs showed an almost 5 fold increased efficiency to 
generate hematopoietic progenitors (CFU-GEMM) as well as other myeloid lineages 
(Armstrong et al., 2005). Lee et al., (2005) did not find any changes in proliferation and 
differentiation in mouse ESC when they over-expressed mTERT. However, they found a 
protection of ES cells against cell death during differentiation and increased resistance to 
apoptosis induced by oxidative stress and other genotoxic insults that depends on the 
catalytic activity of mTERT. 
In addition, TERT over-expression resulted in a decrease in spontaneous as well as induced 
apoptosis rates in ESCs and in embryoid bodies (EBs) at day 6 of differentiation. At the same 
time also the increase in oxidative stress levels during differentiation into EBs was 
significantly attenuated (Armstrong et al., 2005). However, TERT over-expression in human 
ESCs only promoted proliferation and accelerated cell cycle progression, but suppressed 
differentiation properties (number of hematopoietic colonies formed) of TERT over-
expressing cells although they could form all three germ layers in vivo (Yang et al., 2008). 
The reasons for these differences in the differentiation capacity of mouse and human ESC 
after ectopic TERT expression are not clear but could be explained with general differences 
between mouse and human telomere and telomerase biology. Conversely, when TERT and 
telomerase activity levels are severely reduced due to over-expression of a transcriptional 
inhibitor of TERT (Zap) cell growth as well as differentiation potential are significantly 
compromised (Armstrong et al., 2004). 
Comparison of gene expression between normal and TERT over-expressing mESCs revealed 
an up regulation of cell cycle genes (CyclinD1, which was also up regulated in the human 
experiment, Yang et al, 2008), detoxification and differentiation as well as a down regulation 
of two DNA damage and stress-related downstream genes of p53: p21 and Gadd45a 
(Armstrong et al., 2005). These results correspond well with a decreased oxidative stress and 
apoptosis sensitivity as well as with a higher proliferation rate and differentiation capacity 
towards hematopoietic lineages in TERT over-expressing murine ES cells. Interestingly, Tsai 
et al (2010) published recently that over expression of TERT in human mesenchymal stem 
cells increases proliferation and differentiation potential and brings those cells close to 
human ES cells (hESC) in their gene expression and methylation pattern (Tsai et al., 2010).  
Together, these results show that ectopically over-expressed telomerase can mitigate 
increases in ROS and oxidative stress but not diminish them entirely. The mechanism could 
be the delayed down regulation of genes involved in antioxidant defences as well as various 
heat shock factors (Armstrong et al., 2005). This data suggests that stably high levels of 
telomerase might be responsible for the maintenance of high levels of stress defence 
capacities in accordance with findings from our and other groups on hTERT over-expressing 
cells (Fu et al., 200, Zhu et al., 2000, Zhang et al., 2003, Ahmed et al., 2008). 
The data on a protective function of telomerase in differentiated progeny of ES cells are in 
good accordance with telomeric protection of telomerase as well as newly described non-
telomeric functions. In addition to telomere maintenance TERT can also directly change gene 
expression in a telomere-independent fashion by functioning as a chromosomal modulator 
and transcriptional c-factor of the Wnt pathway (Choi et al., 2008, Park et al., 2009). TERT 
therefore can actively influence gene expression levels and interact with important signalling 
pathways in stem cells although this observation has not been extended to embryonic stem 
cells yet. A connection between Wnt signalling and the activation of mitochondrial biogenesis 
and OXPHOS gene expression involved in oxidative phosphorylation has been described in 
immortalised mouse myoblast cells recently (Yoon et al., 2010). 
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In summary, these results also suggest that down regulation of telomerase is usually 
associated with differentiation of ES cells, however, it  does not seem to be essential for the 
differentiation process since ES cells stably over- expressing telomerase retain their 
differentiation capacity. 
4. Long term cultivation and karyotypic stability 
In order to obtain enough stem cells for any potential application in regenerative medicine 
and cell replacement therapies a large amount of cells and consequently, an extensive 
expansion of stem cell cultures would be required. Contradictory data exist about genetic 
instabilities in embryonic stem cells during long term cultivation. ES cells maintain a 
constant telomere length due to the presence of high telomerase levels and also show lower 
rates of genomic mutation than somatic cells even after prolonged in vitro culture. Some 
stem cell lineages that had been grown for a long time in culture retained a normal 
karyotype (Rosler et al., 2004, Buzzard et al., 2004) as well as their epigenetic stability (Rugg-
Gunn et al., 2005) while others described an accumulation of chromosomal abnormalities 
when ES cells were cultured for a prolonged time (Longo et al., 1997, Maitra et al., 2005, 
Armstrong et al, 2005). This might depend on the species (mouse or human) as well as the 
(often sub-optimal) culture conditions.  
Various groups had cultivated human embryonic stem cell lines for around 100 passages 
(Maitra et al., 2005, Park et al., 2008, Xie et al., 2010). Park et al. (2008) and  Xie et al. (2010) 
did not find any gross morphological changes or different expression levels for stem cell 
markers between early and late passages. Both groups consistently reported an increased 
proliferation of ESCs at higher passages, no changes in telomerase activity as well as a 
reduced differentiation ability.  
However, while Park et al. (2008) found no karyotypic changes Xie et al (2010) described 
some karyotypic abnormalities (translocation) in one of the two hES cell lines analysed 
while Maitra and co-workers (2005) and found karyotypic anomalies in 8 out of 9 analysed 
human ESC lines at high passage numbers. These included copy number changes 
(amplifications and deletions of chromosomes, 45%) and gene promoter methylation (90%). 
Interestingly, many of those changes are commonly known to occur in cancer. Both Maitra 
and co-authors (2005) as well as Xie et al., (2010) observed in addition to genomic 
instabilities also changes in mitochondrial sequences and function. Maitra et al. (2005) found 
changes in mitochondrial DNA sequence six heteroplasmic sequence alterations in two of 
nine (22%) late-passage hESC lines, most of them in protein coding regions such as in the 
ATPase6 gene which most likely probably affected the protein function. Xie et al., (2010) 
described a compromised mitochondrial function as well as an increased level of ROS 
production and a higher membrane potential and mitochondrial mass. These two studies 
emphasise that in addition to nuclear changes there seem to occur changes in mitochondrial 
sequence and function as well. Decline in mitochondrial function is a hallmark of cellular 
senescence as well as ageing (Passos et al., 2006, Passos et al.,  2010). In general, little 
research has been conducted on changes in mitochondrial properties of ES cells during 
prolonged culture.  
Since it has been shown recently that telomerase can influence mitochondrial function 
(Santos et al., 2004, Ahmed et al., 2008, Haendeler et al, 2009) it is possible  that in addition 
to telomere-maintenance by telomerase its intracellular localisation could also be important 
for proper mitochondrial function in ES cells.  
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In summary, although contradictory results exist regarding the frequency of various 
genomic and epigenetic changes that might occur during long-term cultivation of human ES 
cells a careful karyotypic analysis has to be performed for cells that are intended to be used 
for regenerative purposes. More data on genome instability will be discussed in connection 
with various oxygen conditions. 
5. Mitochondria, oxidative stress and pluripotency in ES cells: lessons for 
optimal culture conditions 
Mitochondria are important organelles that produce the energy of a cell. In addition, they 
play an essential role for many additional cellular processes including cellular survival and 
differentiation. Therefore, a tight regulation of mitochondrial function and integrity is 
important for all cells, including embryonic stem cells. In contrast, compromising of 
mitochondrial function results in cellular senescence, ageing and age-related degenerative 
diseases (Passos et al., 2006, Passos et al., 2010, Wallace, 2005). New connections and 
mechanisms between mitochondrial properties and stem cells emerge recently and will be 
summarised here. 
Mammalian blastocysts and embryonic stem cells of pre-implantation embryos exist under 
highly hypoxic conditions. While early stage embryos develop low oxygen conditions (1.5% 
in rhesus monkeys, slightly higher in rabbits: 3.5% and hamster: 5.3%) oxygen content 
increases upon implantation of the embryo into the uterus (Fisher and Bavister, 1993). Thus, 
they have a limited oxidative capacity and immature mitochondria. They generate most of 
their ATP via aerobic respiration and glycolysis.  Only when these cells differentiate do their 
mitochondria mature, increase in number and switch to oxidative phosphorylation for 
energy production (Cho et al., 2006). Mitochondrial content increases dramatically when 
oocytes mature (Shoubridge and Wai, 2007). Decreased mitochondrial content in oocytes 
correlates to poor fertilisation efficencies (Santos et al., 2006). During early embryogenesis 
the initial amount of mitochondria (around 150 000-300 000 per human oocyte) gets 
distributed to the dividing cells and is therefore decreased in number per cell. 
Consequently, the mitochondrial number is also low in undifferentiated embryonic stem 
cells that derived from the blastocyst stage embryos. At later stages of pre-implantation 
development mitochondrial DNA replication and transcription are activated. These 
processes coincide with mitochondrial maturation into morphologically typical and 
metabolically active organelles that use oxidative phoshorylation and aerobic respiration for 
ATP generation (Trimarchi et al., 2000). However, at the blastocyst stage in vivo cells of the 
trophoectoderm start mitochondrial maturation and differentiation while the pluripotent 
cells of the inner cell mass have still immature mitochondria and mainly rely on glycolysis 
for energy production (Houghton 2006). Mammalian mitochondrial DNA is around 16kb in 
size and encodes 13 mitochondrial proteins as well as various RNAs (tRNAs and rRNAs). 
All other proteins and factors are encoded in the nucleus and then imported into 
mitochondria. The mitochondrial genome is double stranded and contains no introns. 
Mitochondrial genomes form complexes-nucleoids that reside in the matrix close to the 
inner mitochondrial membrane.  
Undifferentiated embryonic stem cells from both mouse and humans have very small 
cytoplasm (Thomson et al, 1998, Varum et al., 2009) and seem to conserve characteristics of 
small, undeveloped mitochondria which is also reflected in their low mitochondrial mass 
and low mitochondrial copy number (Saretzki et al., 2004, Saretzki et al., 2008, Facucho-
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Oliveira et al., 2007). In addition, these cells have low levels of ATP (Cho et al., 2006) as well 
as low levels of oxygen consumption (Kondoh et al., 2007).  
Facucho-Oliveira et al., (2007) suggested that the maturation of the mitochondrial network 
and pluripotency are mutually exclusive. The authors showed that activation of aerobic 
respiration during differentiation of ESCs coincided with down regulation of pluripotency 
markers. The authors claim that in mouse ES cells the expression of pluripotency markers 
decreased prior to the expansion and maturation of mitochondria during spontaneous 
differentiation. However, they used different pluripotency markers from the classical (Oct4, 
Sox2, NANOG). Surprisingly, they even detected an increased expression of their markers 
(Dppa5, Pramel 7 and NDP52L1) during early differentiation days (up to day3), only after 
that the expression of those markers decreased while changes in mitochondrial copy 
number as well as expression of mitochondrial replication and transcription related factors 
started to increase at or after day 6 respectively. In addition, no direct experimental prove 
was given that the initial decrease of pluripotency markers was indeed causal for 
mitochondrial maturation or just a co-incidence. The same authors claim that a steady-state 
expression of PolG, the mitochondrial DNA polymerase is essential for the maintenance of a 
pluripotent state in ES cells (Facucho-Oliveira et al., 2007). It has been demonstrated by 
various groups that once ES cells differentiated their mitochondrial number increased 
(Saretzki et al., 2008, St. John et al., 2005). This process coincided with the loss of 
pluripotency during differentiation of ESC. St. John et al. (2005) suggest that this is in 
accordance with a concept that each stage of cellular development adjusts its metabolic and 
energetic demands to it oxidative capacity. However, it is not clear whether the correlation 
between pluripotency of the inner cell mass and immature mitochondria is purely 
associative or mutually dependent on each other. 
In accordance with the hypoxic nature in the pre-implantation embryo there is accumulating 
evidence that favours low oxygen for embryonic development in vitro and in vivo.  
Rinaudo et al. (2006) found that mouse embryos cultivated under 5% oxygen showed a gene 
expression pattern which was much more similar to that of in vivo embryos when compared 
with those cultivated under 20% oxygen. This data corresponds to observations from 
Harvey et al. (2004) who found a significant increase in the proportion of ICM cells 
compared with trophectoderm cells when embryos were cultured under 2% oxygen instead 
of 21% oxygen. These results are in agreement with findings that pluripotent cells display an 
increased proliferation under reduced oxygen concentrations (see below). There is evidence 
accumulating that suggests that reducing the oxygen concentration towards physiological 
levels in vivo is beneficial for the in vitro maintenance and pluripotency of hES cells. This 
includes a decrease of spontaneous differentiation while promoting self-renewal and 
maintaining a stable karyotype (Ezashi et al. 2005, Westfall et al. 2008, Forsyth et al. 2006). 
Westfall and co-workers compared gene expression patterns in stem cells under low and 
high oxygen conditions of cultivating stem cells (Westfall et al. 2008). The authors identified 
various genes whose expression was sensitive to oxygen concentrations, many of them 
under the control of hypoxia-inducing factors and genes encoding enzymes involved in 
carbohydrate catabolism and cellular redox state. Although genes associated with 
pluripotency, including OCT4, SOX2, and NANOG were not directly affected, some 
downstream genes such as LEFTY2 were decreased under 20% oxygen (Westfall et al. 2008). 
Zachar and co-workers (2010) analysed human ESC up to 42 month under 20% and 5% 
oxygen and found that while under 20% many cells spontaneously differentiated the 
cultures under hypoxia (5%) better maintained their pluripotency: they continued to express 
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high levels of Oct4 and NANOG as well as telomerase activity. The cultures also retained 
their normal karyotype and were able to differentiate into all 3 germ layers.  
However, other studies found no apparent advantages of culturing hES cells under reduced 
oxygen tension when cells are passaged sufficiently frequent (Chen et al. 2009). 
At least mouse ES cells seem to be not very sensitive against oxidative stress that is even 
higher than 21% oxygen levels (Saretzki et al., 2004) while hESCs might be more delicate in 
their requirements and many studies show an advantage of hypoxic culture conditions. 
Ezashi et al. (2005) found that cultivating human ESC under low oxygen (5%) compared to 
21% of ambient oxygen reduced the amount of spontaneous differentiation dramatically.  
Several lines of evidence seem to explain the beneficial effect of hypoxia with the induction 
of. hypoxia-inducible factors (HIF). For example, Ji et al. (2009) demonstrated the positive 
effect of transcription factor HIF-1alpha on pluripotency and the maintenance of an 
undifferentiated phenotype in human ESCs. The authors co-cultured human embryonic cells 
with human feeder cells that stably expressed HIF-1alpha. Their results demonstrated that 
HIF-1alpha was critical for preventing differentiation of hES cells in culture (Ji et al., 2009). 
At the same time hypoxia also upregulated the expression of NANOG and Oct-4 and of 
some soluble factors including βFGF and SDF-1alpha which are released into the 
microenvironment to maintain the undifferentiated status of hES cells (Ji et al., 2009).  
These results have been confirmed and extended recently by Forrestal et al. (2010). The 
authors also found a faster proliferation and larger colony size in human ES cells cultivated 
up to 12 month under hypoxia (5%) compared to normoxia (21%). Consequently, hES cells 
cultured under 20% oxygen had to be passaged more frequently prior to confluency in order 
to remove differentiated areas, while hES cells under low oxygen were only passaged when 
they reached confluency. Importantly, upon exposure to hypoxic conditions, cells displayed 
a physiological response that ensures availability of sufficient oxygen levels for oxygen-
dependent processes. This response is regulated by hypoxia inducible factors (HIFs) which 
regulate the expression of many downstream genes including various involved in 
erythropoiesis, apoptosis and proliferation (Semenza, 2000). HIFs are transcription factors 
consisting of three oxygen-dependent  subunits: HIF1α, HIF2α and HIF3α. Although 
HIF1α in mouse is the main regulator of hypoxic responses in human ES cells, HIF1α is only 
transiently expressed after hypoxic exposure and predominantly regulates different (mainly 
glycolytic) target genes than HIF2α. The authors identified HiF2α as the directly responsible 
one for the maintenance of pluripotency under hypoxic (5%) oxygen (Forrestal et al., 2010) 
corresponding to earlier findings in mouse ES cells that HIF2α is a direct upstream regulator 
of OCT4 (Covello et al.2006). This data correlated well with a 60-80% reduction in 
expression of pluripotency markers under normoxia. Inhibition of HIF2α and HIF3α, but 
not HIF1α decreased the expression of the pluripotency markers Oct4, Sox2 and NANOG. 
However, only HIF2A silencing correlated to morphological changes of more 
differentiation, a proliferation stop and loss of pluripotency markers (Forrestal et al., 2010). 
Taken together, HIF2α regulated the long-term hypoxic response by controlling hES cell 
pluripotency and proliferation. 
In contrast to other cell types, HIF1α is only responsible for the initial adaptation of cells to 
hypoxia in embryonic stem cells and it was observed in mouse ES cells that expression of 
HIF1α under hypoxia suppressed the LIF–STAT signalling pathway resulting in the 
inhibition of self renewal and the promotion of cell differentiation (Jeong et al. 2007). This 
data provide a greater understanding of the mechanisms which regulate ES cell function 
www.intechopen.com
Telomerase and Oxidative Stress in Embryonic Stem Cells   
 
345 
and the pluripotent state and confirm that environmental oxygen tension has a critical role 
for maintaining of pluripotency in hES cells. 
A direct influence of hypoxia and HIF1α on telomerase expression in mouse ES cells was 
recently established by Coussens et al. (2010). A role for HIF1α for the activation of 
telomerase had already been established in cancer cells previously (Nishi et al., 2004, Yatabe 
et al., 2004). Coussens et al. (2010) used a RNAi screen in order to identify factors that are 
responsible for maintaining a high TERT expression in murine ES cells. Knocking down 
HIF1α did not result in any differences in pluripotency, morphology or growth rate in mES 
cells but it down regulated TERT expression as well as telomerase activity in those cells and 
consequently, also telomeres shortened over 120 population doublings (PDs). The authors 
identified a functional HIF1α binding site at position +1 of the TERT promoter. The 
mechanism for up-regulation of Hif1α levels in cells in response to hypoxia involves a 
posttranslational stabilization of Hif1α via posttranslational modification of specific prolyl 
residues in the oxygen-dependent degradation domain (Ulrich, 2007), however the factors 
that are needed for HIF1α stabilisation are not well understood yet.  Coussen et al. (2010) 
observed that under hypoxic growth conditions both, the targeted and non targeted mES 
cells induced Hif1α levels as well as TERT levels and telomerase activity. The ongoing 
telomere shortening in HIF1α targeted mES cells under long term cultivation resulted 
eventually in a decreased growth rate, increased γH2A.X levels and greatly enhanced p21 
levels-indicative for the occurrence of senescence (although it was not directly shown).  
However, growing Hif1α-targeted cells under hypoxic conditions restored telomerase levels 
and telomere length. This study is the first to demonstrate a direct connection between 
hypoxic culture conditions and telomerase expression that is an important factor for 
pluripotency and unlimited proliferation capacity of undifferentiated stem cells. The authors 
also speculate that HIF1α might be required to sustain high telomerase levels at the inner 
cell mass of the blastocyst since early embryos develop under hypoxic conditions. 
Another paper that seems at odds with the conclusion that a low oxygen atmosphere is 
beneficial for the maintenance of pluripotency was published recently by Varum and 
colleagues (2009). Normal cells decrease the amount of oxidative phosphorylation under 
hypoxic conditions, therefore the authors hypothesised that a further decrease of 
mitochondrial function in ES cells might directly promote pluripotency. They inhibited 
complex III of the mitochondrial respiratory chain pharmacologically and detected a high 
preservation of stem cell features such as high nuclear/cytoplasmic ratio and a specific 
increase in NANOG expression while other pluripotency markers (Oct4 and Sox2) or 
general stemness markers were not changed. In accordance with earlier observations that 
NANOG over-expression prevented neuroectoderm differentiation (Vallier  et al., 2009) the 
authors found that expression of genes involved in ectoderm differentiation was 
significantly reduced in their system due to antimycin A. However, antimycin A treatment 
had a specific interaction with FGFβ signalling in human ES cells. Complex III is directly 
involved in the electron flow and ATP production of mitochondria, but has also been shown 
to directly generate ROS (Hamanaka and Chandel, 2009). Treatment of ESCs with antimycin 
A resulted in impairing of mitochondrial respiration and to a shift from oxidative 
phosphorylation to glycolysis while ATP levels were maintained at a constant level. In 
addition, this treatment increased ROS generation while apoptosis and cell proliferation 
were unchanged (Varum  et al., 2010). There seemed to be a direct correlation between ROS 
generation after antimycin A treatment and NANOG expression since quenching ROS by 
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using a MnSOD mimetic diminished any increase in NANOG expression. These results 
suggest that ROS generated at complex III could be at least partially responsive for the 
effects of antimycin A on NANOG expression levels.  
While many other studies had demonstrated an increase of pluripotency under low oxygen 
levels Varum and co-authors (2010) showed that a certain level of ROS seemed necessary 
specifically for a high expression of NANOG. From these data it could be speculated that 
modulation of mitochondrial function has a rather specific effect on skewing the 
differentiation probability of specific, in this case ectodermic, lineages. It could also mean 
that specific oxidative conditions favour the differentiation of certain tissues, however, more 
evidence for that has to be gathered before any meaningful conclusion can be drawn. 
A possible explanation for the apparent difference between the papers that showed a 
benefical effect of hypoxia on pluripotency of ES cells and the one published by Varum et al. 
(2009) is that it had been shown that ROS generation at mitochondria is responsible for the 
propagation of a hypoxic signal (Chandel et al., 1998). Complex III produces increased 
amounts of ROS under hypoxia which is similar to inhibition of complex III with antimycin 
A (Hamanaka and Chandel, 2009). Hypoxia-induced mitochondrial ROS inhibit HIF-α 
subunit turnover. Therefore it seems that mitochondrial ROS are required for hypoxic 
activation of HIFs and that ROS generation at mitochondrial complex III in particular is 
critical for hypoxia signalling. While complex I inhibitors such as rotenone inhibit the 
induction of HIF-1α, antimycin A does not (Chandel et al., 1998, Chandel et al., 2000). Guzy 
et al. (2005) found that a functional complex III of the mitochondrial electron transport chain 
(ETC) is required for the hypoxic stabilization of HIF-1α and HIF-2α and that an increase in 
ROS from complex III results in a stabilisation of HIF-α subunits. These results suggest that 
mitochondria function as cellular oxygen sensors and signal hypoxic HIF-α stabilisation by 
releasing ROS to the cytosol. Thus, mitochondrial ROS seem to act upstream of prolyl 
hydroxylases in regulating the stability of both HIF-1α and HIF- 2α  in mammalian cells. 
However, whether oxidative stress and ROS production is either decreased (Richter  and 
von Zglinicki, 2007) or increased (Hanaka and Chandel,2009) under hypoxia is still 
controverse and might  to a large degree depend on the actual oxygen percentage (1-5%) as 
well as changes in oxygen concentration during cell handling which might favour re-
oxygenation that leads to increased ROS. 
Evidence for very specific influences of mitochondria on stem cells has been recently 
demonstrated by Todd et al. (2010). The authors used loss and gain of function experiments 
in order to show that the growth factor Gfer plays a very specific role in stem cells, but not 
in somatic cells. The factor is present in mitochondria as well as in the nucleus and 
cytoplasm and seems to be highly enriched in various types of stem cells including 
embryonic. By influencing the mitochondrial fission factor Drp1 Gfer promotes survival and 
pluripotency in mouse ESCs (Todd et al., 2010). Down regulating Gfer in mouse ESCs 
decreased pluripotency markers, mitochondrial membrane potential and resulted in 
mitochondrial fission and fragmentation, a sign of cellular stress. At the same time the 
damaged mitochondria were eliminated by autophagy and apoptosis. This data suggests 
that dysfunctional mitochondria are effectively cleared from embryonic stem cells thereby 
ensuring a high quality of mitochondria remaining within the stem cells. While the level of 
Drp1 was increased when Gfer levels were decreased a decrease of Drp1 rescued 
mitochondrial dysfunction, pluripotency and apoptosis in Gfer depleted cells (Todd et al., 
2010). Although the authors have not directly characterised glycolysis and energy 
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generation in those ES cells their data would suggest that embryonic stem cells rely on 
functional and healthy mitochondria rather than undeveloped and non functioning ones. 
However, nothing is known about the role of Gfer in human ES cells and more research is 
needed to clarify and understand this apparent contradiction as well as the direct role of 
mitochondria for pluripotency. 
6. Redox regulation in ES cells 
Oxidative stress can be generated endogenously by dysfunctional mitochondria and NADH 
oxidases or applied externally via cell culture conditions or drugs and agents. It recently has 
been shown to control self renewal and differentiation of embryonic stem cells. ROS are 
generated in cells by enzymatic as well as non-enzymatic pathways. NADPH oxidases and 
xanthine oxidase generate superoxide anions by reducing molecular oxygen. In 
mitochondria superoxide leaks during electron transport from complexes I and III. 
However, at the same time there are many different ways in a cell to counteract oxidative 
stress. A first defence are antioxidant enzymes such as superoxide dismutases that 
dismutate the superoxide anions to hydrogen peroxide, which then is further scavenged by 
peroxidases, catalase or other molecular scavengers such as vitamins, carotinoids etc. 
Therefore, there generally exists a very balanced homeostasis of oxidative stress and redox 
state within a cell. Disturbing that balance can lead to increased oxidative stress and result 
in damage of DNA, lipids and proteins. On the other hand, ROS are also an important 
intracellular signalling factors (Finkel, 2001, Schieke and Finkel, 2006 Starkov 2008).  
A better understanding of the influence of culture and environmental conditions should 
help to optimise growth conditions for undifferentiated and differentiated ES cells. Thus, it 
will also impinge on the successful application of those cells for the purpose of regenerative 
medicine. 
Evidence is emerging currently that distinct functions of stem cells are under the influence 
of a redox potential. For example, low oxygen keeps hematopoietic stem cells in a quiescent 
state while higher ROS promote their differentiation (Hosokawa et al., 2007). 
Recently, Yanes and colleagues (2010) uncovered a mechanism how increased oxidative 
stress not only accompanies differentiation of ES cells as described earlier (Saretzki et al., 
2004, Saretzki et al., 2008) but seems to drive it actively. The authors performed an 
untargeted metabolomics approach in order to compare pluripotent mouse embryonic stem 
cells and their differentiated progeny. They also used metabolites involved in and produced 
by oxidative pathways in order to characterise their role in pluripotency and differentiation. 
They found that embryonic stem cells are characterised by an abundance of metabolites 
with highly unsaturated structures that decrease during differentiation. Some of the most 
up-regulated metabolites were secondary lipid messengers as well as inflammatory 
mediators. These unsaturated metabolites are preferentially susceptible to pro-oxidative 
events that occur due to intracellular changes in redox status. As evidence the authors 
monitored the ratio of reduced and oxidised glutathione (GSH/GSSG) during the course of 
differentiation. Oxidative stress is known to change that ratio due to conversion of GSH into 
GSSG. While the GSH/GSSG levels decreased by day 4 of differentiation ascorbic acid (an 
important antioxidant) levels increased during the same time pattern. The authors conclude 
that cell differentiation is associated with an increase of oxidative stress, an observation 
corresponding to findings from our laboratory (Saretzki et al., 2004, Saretzki et al., 2008). To 
prove that activation of an oxidative pathway is indeed necessary for cellular differentiation 
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they inhibited the eicosanoid signalling pathway. That resulted in a promotion of 
pluripotency (increase of Oct4 and NANOG expression) and a reduction of differentiation in 
a dose dependent manner of inhibitors. Accordingly, when treated with eicosanoids, 
differentiation was promoted. These pathways acted similarly in human ESCs (Yanes et al., 
2010). These results correspond well to an increased pluripotency in ESCs grown under 
physiological (5%) oxygen instead of normoxia (see above). They also correspond to 
findings of Eitsuka et al. (2005) who found that unsaturated, but not saturated fatty acids 
decreased telomerase activity and hTERT expression. In particular, polyunsaturated fatty 
acids (PUFAs) like EPA and DHA, were identified as powerful telomerase inhibitors 
mediated via protein kinase C (Eitsuka et al. 2005). These results identify an additional 
mechanism (in addition to epigenetic changes) how telomerase might be down regulated 
during ES cell differentiation and adds another component to the study (Yanes et al. 2010).  
Powers et al (2008) analysed mouse ES cells under various oxygen levels and found that these 
cells adapted well to all oxygen conditions while maintaining pluripotency markers and an 
undifferentiated state. The authors found that the cells adapted their metabolism accordingly 
and generated constant ATP levels, although to a different degree by aerobic respiration in 
dependence on the oxygen conditions (Powers et al., 2008). However, once differentiated 
oxygen conditions had a substantial effect on the function and properties of those cells. Only 
extremely low oxygen concentrations lower or equal 1% induced differentiation of mouse ES 
cells. That could mean that a certain amount of oxygen is needed to maintain a pluripotent and 
undifferentiated state in mouse ES cells confirming the results obtained by Varum et al., (2009).  
The results from Powers et al (2008) are in accordance with our findings that mouse ES cells 
proliferate undistinguishable under normoxia (21%, ambient oxygen) and under hyperoxia 
(40% oxygen) (Saretzki et al., 2004). Powers et al (2008) did not find any difference in DNA 
damage due to different oxygen concentration, but could correlate the damage levels with 
increasing amounts of hydrogen peroxide. However, these results seem to be at odds with 
the findings of Li and Marban, (2010) who found a four fold higher DNA damage levels 
under 20% oxygen than under 5%. However, while Powers et al (2008) used mouse ES cells, 
Li and Marban (2010) used human stem cells which might explain the differences in DNA 
damage sensitivities.  
In addition to growing human ES cells under physiological oxygen (5%) Li and Marban 
(2010) as well supplemented the culture media with various antioxidants. The latter were 
much more powerful in reducing intracellular ROS levels than hypoxia. Surprisingly, there 
was a biphasic dosage-dependent response to the treatment with antioxidants: while at low 
concentrations they reduced DNA damage, high concentrations promoted DNA damage.  
Importantly, the authors found that high doses of antioxidants decreased the level of 
proteins involved in DNA damage response such as DNA damage mediating kinases ATM 
and ATR and other downstream DNA repair factors such as Rad50, Rad 51, Chk1 and Chk2 
(Li and Marban, 2010). The authors discussed this observation as a concept of “oxidative 
optimum” and concluded that a certain level of ROS are necessary in order to activate the 
DNA repair pathway and maintain chromosomal stability and genomic integrity, at least in 
stem cells. This data suggests that ROS not also induce DNA damage but at the same time 
are also able to promote the DNA damage response that in turn induces DNA repair.  
Thus, instead of a low oxygen content (hypoxia) also antioxidants could be supplemented to 
the culture medium, however their concentrations have to be carefully optimised in order to 
avoid any detrimental effect as demonstrated by Li and Marban (2010). 
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To read more about the current knowledge of cultivating ES cells under low oxygen see 
Millman et al, (2009) for review. 
Napier et al. (2010) showed recently that 20% oxygen concentration down regulated the 
levels  of the RNA component hTR of the telomerase complex in endothelial cells thus 
hampering telomere maintenance by telomerase. These findings correspond well with the 
up regulation of TERT expression due to HIF1α under hypoxia (Coussens et al., 2010).  
7. P53 and DNA damage response in ES cells 
Cells are constantly under environmental and metabolic conditions that may cause genetic 
damage. Various environmental factors can lead to DNA damage that, if not repaired lead 
to either apoptosis and senescence or  to genomic instabilities.  
It is imperative for ES cells which give rise to all cells of the body and, most importantly, 
any germ cells, to guarantee a low mutation load and minimise any influence of genomic 
instability and DNA damage. ES cells have extremely stringent mechanisms in place that 
ensure a high degree of genomic integrity. Spontaneous mutation rates are around 100 fold 
lower in ES cells than in differentiated somatic cells (Cervantes et al, 2002). One of the most 
remarkable properties of ES cells is their high stress resistance (Saretzki et al., 2004, Saretzki 
et al., 2008, Guo et al, 2010). Mouse ES cells are very resistant against an increase in external 
oxidative stress and proliferated with the same rate in 20% and 40% oxygen (Saretzki et al., 
2004). In addition, when compared to other immortal mouse cells such as 3T3 which both 
express high and comparable telomerase levels, mES cells accumulated less DNA damage 
when gamma-irradiated and had a better or faster DNA repair capacity (Saretzki et al., 
2004). This seems to reflect a better DNA repair capacity as well as a high amount of 
antioxidant enzymes as shown at the gene expression level for mouse and human ES cells 
alike (Saretzki et al., 2004, Saretzki et al., 2008). In general, there seem to be two main 
pathways how ES cells cope with DNA damage: apoptosis and differentiation. 
The tumour suppressor molecule p53 is one of the most important response mechanisms 
that operate in most somatic cells and play an important role in maintaining genomic 
integrity. Without any endogenous or exogenous stress p53 is expressed at a low level and 
remains inactive due to interaction with MDM2 and rapid ubiquitinylation and degradation 
of the protein.  Only after stress occurs it is quickly stabilised and activated. The pathway 
ensures that cells that underwent DNA damage can halt their cell cycle in order to repair the 
damage or alternatively, if the damage is too high and cannot be repaired, drive cells into 
apoptosis or senescence. However, the p53 signalling pathway seems very differently 
regulated in ES cells compared to somatic cells. p21 is considered to be an important 
component in the senescence pathway and thought to correlate with ROS generation (Macip 
et al., 2002, Passos et al., 2010). In somatic cells the DNA damage response pathway activates 
p53 which in turn induces the expression of its downstream target genes such as p21. 
Consequently, high levels of p21 following extensive DNA damage had been implicated as a 
hallmark for DNA damage-induced premature senescence (Waldman et al., 1995).  
Aladjem et al. (1998) have challenged mouse ES cells with an antimetabolite that depleted 
ribonucleotides and DNA damaging agents. They found that mouse ES cells have a high 
level of p53 protein but it was mainly localised in the cytoplasm and did not localise to the 
nucleus as in differentiated cells. P53 was therefore not able to act as a transcription factor 
for downstream genes such as p21 in the nucleus. Consequently, it did not activate a cell 
cycle arrest after rNTP depletion or DNA damage. Instead, cells went into apoptosis that 
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was independent of p53 (Aladjem et al., 1998). The authors showed that the p53 checkpoint 
became operational again once the ES cells were differentiated (Aladjem et al., 1998). On the 
basis of this and other papers (Hong and Stambrook, 2004) it was thought that mouse ES 
cells lack a G1 dependent cell cycle arrest and have a deficient p53 DNA damage response. 
Miura et al. (2004) suggested that p53 is not required for ES cell self renewal and early 
embryogenesis  and that also the RB/E2F pathway is inactive in ES cells thereby uncoupling 
mitogenic signalling from cell cycle progression.  
It is well accepted that mouse and human ESC have a unique cell cycle structure different 
from somatic cells. They show only a very short and rather transient G1 and G2 cell cycle 
phases while most cells are in S-phase (Becker et al., 2006). Becker et al. (2006) described the 
shortened G1 cell cycle phase of human embryonic stem cells as necessary for their self 
renewal properties. Due to their very short G1 phase it was believed for some time that ES 
cells lack a G1 dependent growth arrest upon DNA damage. 
However, recently a transient cell cycle arrest has been described in mouse and human ES 
cells. Barta and colleagues (2010) exposed human ES cells to UVC irradiation in G1 phase 
and found a cell cycle arrest just before DNA synthesis in S-phase. They found a down 
regulation of the cyclin-dependent kinase 2 activity depending on the checkpoint kinases 
Chk1 and Chk2 (Barta et al., 2010). The authors conclude that human ES cells are able to 
prevent entry into S-phase upon DNA damage by activating a G1/S arrest that is 
independent of p53 and p21 activation. 
Lin et al. (2005) have described a role for p53 in the maintenance of a high genomic stability 
of ES cells by driving damaged ES cells into differentiation and thereby eliminating them 
from the ES cell pool. The mechanism for that seemed to be a direct down regulation of 
NANOG expression by p53 in mouse ES cells after DNA damage. NANOG is an important 
pluripotency associated transcription factor and essential for embryonic survival. The 
authors found a marked increase in p53 expression 4 hours after the treatment when 
apoptosis was not detectable yet. The authors also showed the activation of downstream 
genes such as Noxa and Puma proving that p53 was transcriptionally active. The decrease 
was specific for NANOG and not due to differentiation since other pluripotency markers 
such as Oct3/4 were stably highly expressed. P53 directly bound the NANOG promoter 
with higher efficiency than the p21 promoter. They also demonstrated that p21 was 
increased during differentiation of mouse ES cells due to active p53 (Ser 315 
phosphorylation) although the overall p53 protein level decreased (Lin et al., 2005). Most 
importantly, down regulation of NANOG as well as successful differentiation induced by 
retinoid acid was dependent on Ser 315 phosphorylation of p53. Apoptosis induction was 
dependent on the presence and activity of a functional p53 (Lin et al., 2005) contradicting 
findings from others that a p53 dependent cell cycle arrest and apoptosis induction might 
not be operating in ES cells after various DNA damage inducers (Aladjem et al.,1998, Guo et 
al., 2010).  
Mora-Castilla et al (2010) recently confirmed the role of p53 Ser315 phosphorylation for 
NANOG down regulation during differentiation of mouse and human ES cells following the 
exposure to NO-inducing agents. They showed that both p53 Ser315 and trimethylated 
histone H3 bound and repressed the NANOG promoter. Epigenetic modification of Oct4 
and NANOG had been previously demonstrated during ESC differentiation (Wang et al., 
2009). 
Qin and colleagues (2006) demonstrated a direct link between p53 and apoptosis induction 
in human ES cells. They confirmed that treatment with DNA damaging agents accumulated 
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p53 but did not activate its transcriptional targets such as p21. The authors demonstrated 
that this could be due to differential modification/phosphorylation of p53 in ES cells 
although p53 still binds to the promoters of p21 and Noxa after DNA damage. p53 was still 
able to bind to the promoters and down regulate the pluripotency genes Oct4 and NANOG.  
However, instead of transcriptional regulation p53 induced apoptosis in ES cells via a 
transcription-independent mitochondrial pathway. Like others the authors also observed 
that p53 is involved in spontaneous differentiation. This study proves the important role of 
p53 for the survival and differentiation of ES cells. P53 seemed also directly responsible for 
down regulating Oct4 and NANOG after DNA damage treatment  via p53 binding to the 
promoters of both genes, while decreasing p53 levels correlated with an amelioration of this 
down regulation. Over-expressing Mdm2 could inhibit p53 accumulation and reduced 
spontaneous apoptosis levels. The authors also suggested that a decrease of p53 levels due 
to lowering stress during cultivation such as free oxygen radicals could be beneficial for 
growth and expansion of ES cells in culture. In summary, the study of Qin et al (2006) 
suggests that there is a very specific mechanism of p53 regulation that is active in ES cells 
but not in differentiated and somatic cells.  
In general, it seems that p53 is a suppressor of pluripotency in ESC because it suppresses 
self-renewal of ESC after DNA damage. Thus, p53 seems to play an important role for the 
maintenance of genomic stability of ES cells by influencing their DNA damage response and 
self-renewal properties (Zhao and Xu, 2010).  
Both mouse and human embryonic stem cells (ESCs) are unique among all stem cells by 
replicating continuously and being immortal in the absence of replicative senescence (Zheng 
and Rao, 2007, Guo et al., 2010).  
8. Telomerase and mitochondria during the induction of pluripotency from 
somatic cells 
Induced pluripotency cells (iPSCs) are a stem cell population that is experimentally derived 
from somatic cells by forced expression of various transcription factors that are normally 
expressed in embryonic stem cells. These cells acquire many properties of normal ES cells, 
including a high self-renewal potential, gene expression, high telomerase activity and 
differentiation potential as well as low mitochondrial number (Armstrong et al., 2010).  
The generation of iPS cells is very promising in order to analyse and model detailed disease 
mechanisms in vitro. In addition, this procedure opens even greater regenerative potential 
than normal ES cells since in theory a somatic cell can be taken from the same donor who 
then receives the transplant from differentiated iPS cells. This type of custom tailored cell 
generation has enormous potential, but several processes have not yet been understood 
sufficiently and have to be solved in order for any potential cell replacement to be safe.  
Induced pluripotency cells (iPSCs) were for the first time generated from mouse somatic 
cells by Takahashi and Yamanaka in 2006 (Takahashi Yamanaka, 2006). The authors used a 
cocktail of 4 essential transcription factors: Oct4, Sox2, KLF4 and c-myc. The latter two are 
thought to induce telomerase (Wong et al., 2010) however myc seems not really necessary 
for iPS induction. Meanwhile many groups repeated and refined this method in the mouse 
and the human system (Marion et al., 2009, Armstrong et al., 2010). In principle the 4 
transcription factors re-programme the epigenetic signature of a somatic cell into that of an 
undifferentiated embryonic stem cell, including telomeres (Marion et al., 2009).  
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These properties are also reflected during the generation of induced pluripotency cells 
(iPSCs). One striking example is the activation of telomerase during the induction of 
pluripotency. It occurs in human, but is much less robust in mouse ES cells (Mathew et al., 
2010). iPS cells, as normal stem cells are characterised by a high level of telomerase 
expression. Apparently, a high telomerase expression level in necessary in human iPS cells 
in order to re-elongate telomeres to the length of embryonic stem cells. A stable long 
telomere length is an essential prerequisite for self-renewal capacities of embryonic as well 
as iPS cells. Maria Blascos’ group has provided a direct evidence for the importance of 
telomere length reset in iPS cells. Efficiency of iPS generation was dramatically reduced 
when cells from late generation telomerase (TERC) knockout mice were used that do not 
have telomerase activity and have very short telomeres (Marion et al., 2009). However, they 
also noticed, that some iPS clones from G2 and G3 generation TERC knock-out mice could 
have activated telomerase-independent telomere elongation mechanisms. The importance of 
telomere length and telomerase activity is evidenced by the finding that re-introduction of 
telomerase into telomerase knock-out mice is able to re-adjust telomere length and promote 
efficient iPS cell derivation. However, more important than the average telomere length for 
iPS cell derivation is probably the absence of very short individual telomeres.  
The authors also found that during the normal iPS cell derivation process telomeres acquire 
embryonic stem cell properties including telomere length and epigenetic changes (Marion et 
al., 2009).  
Mathew et al. (2010) demonstrated in detail that telomerase activation and TERT promoter 
activation occurred at discrete steps during reprogramming of somatic cells. Comparing 
mouse and human cells they found a very modest threefold increase of the mTERT 
promoter activity during reprogramming while the hTERT promoter was induced between 
10 fold (partial reprogramming) to hundred fold (complete reprogramming) in different 
colonies. While many clones had telomerase activity up regulated only those with the 
highest levels were able to maintain their telomeres (Mathew et al., 2010). Since mice have 
much longer telomeres in their somatic cells than humans it seems highly likely that human 
cells have to activate hTERT and telomerase to a much larger extent than it is necessary in 
mouse cells. 
Many promoters such as the one from NANOG were hypomethylated in ES cells and 
demethylated during iPS cell generation (Mathew et al., 2010). However, the hTERT 
promoter was not highly methylated in somatic cells and demethylation events did not play 
an essential role in its re-activation while the histon modification of the promoter changed 
substantially during re-programming (Mathew et al., 2010). A general similarity but not 
identity had been shown for gene expression patterns of ES cells and iPS cells (Prigione et 
al., 2010). Similarities were described for most pluripotency and self-renewal genes while 
differences could be due to a conservation of some donor cell characteristics since both cell 
types did not derive from the same individual. 
Progione et al. (2010) recently demonstrated that iPS cells derived from human skin also 
shared similarities with ES cells regarding their reduced p53 activity and mitochondrial 
activity including low ROS levels. A decrease in mitochondrial copy number and mass were 
also confirmed by others (Armstrong et al., 2010).  
Since all mitochondria within iPS cells derive from a somatic cell the authors were interested 
in the analysis of how mitochondria from somatic cells are able to acquire stem cell like 
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properties. They showed that somatic mitochondria re-acquire an immature phenotype 
which resembled that of ES cells. This included an ESC like state of morphology, biogenesis 
factors, mitochondrial copy number and a decreased level of ATP as well as oxidative stress 
generation (Prigione et al., 2010). iPS cells like ES cells relied on glycolysis rather than 
oxidative phosphorylation for their energy generation. 
Progione and co-authors also showed a lower amount of oxidatively modified DNA lesions 
(oxodG) in undifferentiated ES cells and iPS cells and confirmed also a higher resistance to 
oxidative stress and DNA damage shown by our group previously (Saretzki et al., 2004, 
Saretzki et al., 2008, Armstrong et al., 2010). However, while Prigione et al. (2010) found a 
decrease in the expression of antioxidant enzymes such as catalase, GPX1 and all three SODs 
in undifferentiated iPS and ES cells that increased during differentiation our group detected 
the opposite: high antioxidant gene expression in undifferentiated ES cells, but a decrease 
during differentiation (Saretzki et al., 2004, Saretzki et al., 2008). Further analysis, such as 
comparing the expression at the protein or activity levels seem necessary to resolve this 
discrepancy.  
Prigione et al. (2010) concluded that reprogramming restored a cellular state characterised 
by immature mitochondria and low oxidative stress. It is an intriguing finding that it seems 
to be possible to rejuvenate mitochondria so that they escape cellular senescence. 
Mitochondria and mitochondrially generated oxidative stress are thought to be important 
components in the induction of cellular senescence and human ageing alike (Wallace, 2005, 
Passos et al., 2010). In contrast, long telomeres, low p53 and p21 activity as well as low levels 
of oxidative stress and immature mitochondria are hallmarks of embryonic stem cells 
(Saretzki et al., 2004, Saretzki et al., 2008, Facuchi-Olivera et al., 2007). Furthermore, there is 
evidence to suggest that telomerase that resides inside the mitochondria actively decreases 
oxidative stress although the mechanism remains elusive yet (Ahmed et al., 2008, Haendeler 
et al., 2009). 
Recapitulation of immature mitochondria might also suggest that this state is important for 
the generation of iPS cells and possibly causally involved in the establishment of 
pluripotency. However, further research is necessary to establish a direct connection 
between mitochondrial state and pluripotency. 
However, some mechanisms that enhance the efficiency of iPS cell derivation at the same 
time also raise concern about the possible risks of application of cells derived from iPS cells 
generated after inhibition of the p53 pathway. A decrease of p53 has been shown to increase 
the efficiency of iPS cell derivation (Hong et al., 2009). However, it remains elusive whether 
the p53 induced senescence or apoptosis are involved in this block of reprogramming. Since 
many cancer types inactivate this important tumour suppressor pathway it remains 
controversial whether this could increase the cancer risk for patients treated with iPS cells 
that have been derived by compromising the p53 checkpoint (Zhao and Xu, 2010).  
9. Conclusion 
High telomerase expression as well as a special mitochondrial state are both characteristic 
properties of embryonic stem cells in addition to pluripotency. Our group was the first to 
analyse oxidative stress and stress resistance in normal and TERT over-expressing ES cells 
(Saretzki et al., 2004, Armstrong et al., 2005, Saretzki et al., 2008, Yang et al., 2008).  
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Recently, evidence emerges that favours hypoxic condtitions for the improvement of 
proliferation, pluripotency and differentiation capacities in ES cells. A direct link between 
HIF1α and telomerase function provides some rational for that (Coussens et al., 2010). 
More data and possible mechanisms emerged on the role of reactive oxygen species (ROS) 
and the differentiation and pluripotency of ES cells. In particular, the role of mitochondria 
for ES cell properties gains more and more interest. Specific mitochondrial regulatory 
pathways that operate only in embryonic stem cells have been demonstrated recently (Todd 
et al., 2010) and ROS have been identified as possible differentiation inducer (Yanes et al., 
2010).  
Other new results emerge recently to explain why the tumour suppressor checkpoint p53 
operates via a mitochondrial pathway that promotes apoptosis rather than cell cycle arrest 
or premature senescence as in somatic cells rather than via transcriptional control (Qin et al., 
2007). Others have shown that p53 promotes differentiation of ES cells via downregulation 
of NANOG (Lin et al., 2005). 
Induced pluripotency derived cells recapitulate mitochondrial numbers and properties 
known from early embryonic development under low oxygen conditions. However, no 
direct causal relationship between mitochondria and pluripotency has been investigated to 
date.  
My group was the first to show a direct correlation between telomerase that shuttles to 
mitochondria and improved mitochondrial properties and a decreased oxidative stress 
(Ahmed et al., 2008). Other non-canonical functions of telomerase include its involvement in 
gene expression and Wnt signalling (Choi et al., 2008, Park et al, 2009). Interestingly, Yoon et 
al (2010) uncovered a new link between Wnt signalling and mitochondrial biogenesis and 
gene expression involved in oxidative phosphorylation. Bringing the different components 
involved in regulation of stem cell properties including mitochondria and telomerase 
together will certainly result in a better understanding of ES cell properties.  
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